4.5 Article

Current practices and future trends in cockroach allergen immunotherapy

Related references

Note: Only part of the references are listed.
Article Allergy

Combination therapy of specific aeroallergens immunotherapy and omalizumab, in children with severe asthma

Laura Valdesoiro-Navarrete et al.

Summary: This study aimed to analyze the safety and efficacy of combining omalizumab (OM) with allergen-specific immunotherapy (AIT) in children with severe asthma. The results showed that the combined treatment of OM and AIT was safe and effective, improving asthma control and lung function in pediatric patients.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2022)

Article Immunology

Per a 5-derived T-cell peptides modulate NF-kB signalling to ameliorate allergic inflammation systemically in murine model of cockroach allergic hyper-reactivity

Swati Sharma et al.

Summary: This study found that TC-P1 and TC-P3 peptides can resolve pulmonary inflammation by expanding regulatory T cells and downregulating NF-kB signaling in a murine model of cockroach allergy hypersensitivity. Peptide immunotherapy shows potential for treating allergic inflammation.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2022)

Article Immunology

Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study

Clara Padro et al.

Summary: This study conducted a real-life study on patients with house dust mite-induced allergic asthma, and the results showed that Acarovac Plus (R) treatment was effective and safe.

IMMUNITY INFLAMMATION AND DISEASE (2022)

Article Allergy

Combination of immunotherapies for severe allergic asthma

Askin Guelse et al.

Summary: Biological drugs are an alternative therapy for treating patients with refractory asthma, while allergen-specific immunotherapy (SIT) is a causative treatment option for allergic asthma. This case study demonstrates the effectiveness of an individualized approach and phenotype-specific treatment in successfully treating a patient with severe allergic asthma using SIT after achieving asthma control with target treatments.

JOURNAL OF ASTHMA (2021)

Article Biochemistry & Molecular Biology

In vivo Targeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long-Lasting Immunity against Melanoma

Gopikrishna Moku et al.

Summary: The study introduces lipid nanoparticles with a novel design for selective targeting of dendritic cells in vivo through the mannose receptor. These nanoparticles were found to stimulate long-lasting immune responses under prophylactic conditions and significantly delayed melanoma growth under therapeutic settings, demonstrating a promising approach for delivering DNA vaccines to dendritic cells with high efficacy.

CHEMBIOCHEM (2021)

Article Biochemistry & Molecular Biology

Immunomodulatory Response of Toll-like Receptor Ligand-Peptide Conjugates in Food Allergy

Jorge Losada Mendez et al.

Summary: The covalent conjugation of allergens to toll-like receptor (TLR) agonists is a powerful strategy for developing safe compounds for allergen-specific immunomodulatory response towards tolerance in allergy. Synthesizing two families of ligands, one as a ligand for TLR7 and the other for TLR4, both conjugated with a T-cell peptide of Pru p 3 allergen, showed promising results in inducing specific maturation of dendritic cells, T-cell proliferation, and cytokine production in peach allergic patients. The increase in Treg-cell frequencies and induction of IL-10 production in patients suggest the potential application of these allergen-adjuvant systems in food allergy immunotherapy.

ACS CHEMICAL BIOLOGY (2021)

Review Allergy

Novel vaccines for allergen-specific immunotherapy

Oluwatoyin Akinfenwa et al.

Summary: The review emphasizes the importance of molecular allergy diagnosis in accurate prescription and monitoring of allergen-specific immunotherapy (AIT), as well as the potential of new molecular approaches in improving treatment success. Experimental approaches, such as virus-like particles and cell-based treatments, and the significance of allergen-specific IgG antibodies for the success of AIT, including the development of new molecular vaccines for prophylactic allergen-specific vaccination, are highlighted in the review.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Allergy

Role of nanostructures in allergy: Diagnostics, treatments and safety

Cristobalina Mayorga et al.

Summary: Nanotechnology, conducted at the nanoscale, has led to the development of nanomaterials with wide applications in biomedicine, while facing challenges such as toxicity and hypersensitivity responses that require evaluation and resolution. The application of nanoengineered materials in allergy diagnosis and specific immunotherapy shows promising prospects for improving sensitivity and efficacy.

ALLERGY (2021)

Article Immunology

Integrin αvβ6 cooperates with resiquimod to restore antigen-specific immune tolerance in airway allergy

Fei Ma et al.

Summary: The study shows that utilizing a bio-nanoparticle called Rexo can effectively restore immune tolerance in subjects with airway allergic diseases. Rexo inhibits experimental AAD by inducing antigen-specific T cells, demonstrating therapeutic potential.

IMMUNOLOGY LETTERS (2021)

Article Allergy

Intranasal delivery of allergen in a nanoemulsion adjuvant inhibits allergen-specific reactions in mouse models of allergic airway disease

James R. Baker et al.

Summary: Therapeutic immunization with allergen in NE effectively suppresses allergic airway inflammation and bronchial hyper-reactivity in mouse models, suggesting that ILC2 cells may be crucial targets for this activity.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Review Allergy

Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy

Lisa Englert et al.

Summary: Recent years have seen significant momentum in the development of medicinal products for allergen immunotherapy (AIT) of food allergies. Unique challenges arise in the manufacturing processes and controls of these products, as the source materials are typically produced for food consumption, not medicinal purposes. Quality control for these AIT products includes determining protein content, total allergenic activity, and major allergen content, while ensuring consistency in batch production.

CURRENT ALLERGY AND ASTHMA REPORTS (2021)

Review Allergy

Respiratory sensitization to insect allergens: Species, components and clinical symptoms

Yuma Fukutomi et al.

Summary: Airborne insect particles are identified as a significant cause of respiratory allergies, not only among occupationally exposed individuals, but also among asthma and rhinitis patients with no occupational exposure to insects. Cockroaches and booklice are common indoor insects associated with asthma development and exacerbation, while moths are considered a significant seasonal outdoor allergen.

ALLERGOLOGY INTERNATIONAL (2021)

Article Engineering, Biomedical

A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies

Byoungjae Kim et al.

Summary: This study established a DC-based therapeutic approach using CRISPR/Cas9-mediated targeted gene disruption to alleviate allergic reactions associated with allergic rhinitis. Targeting VPS37A/B enabled reduction of Th2 cytokine production and alleviation of AR-related symptoms in mouse models, providing a promising strategy for treating allergic diseases.

BIOMATERIALS (2021)

Article Immunology

A Component-Resolved Therapeutic Vaccine for Cockroach Allergy Made of Per a 9 and Transforming Growth Factor-β Homologue, an Immunosuppressive Protein of Brugia malayi

Pannathee Prangtaworn et al.

Summary: The study investigated the efficacy and mechanism of a novel intranasal vaccine for cockroach allergy, which showed promising results in reducing pathogenic type 2 responses and lung immunopathology. The vaccine was able to modify immune responses towards a regulatory profile, with potential for broad therapeutic effects for inhalant allergies. Further evaluation for clinical application is warranted.

FRONTIERS IN IMMUNOLOGY (2021)

Article Allergy

ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

Jean Bousquet et al.

CLINICAL AND TRANSLATIONAL ALLERGY (2021)

Article Allergy

Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity

Angelika Tscheppe et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Allergy

Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens

Federico Storni et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Allergy

Towards definitive management of allergic rhinitis: best use of new and established therapies

Lubnaa Hossenbaccus et al.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)

Review Immunology

Human Papillomavirus Vaccines: An Updated Review

Liqin Cheng et al.

VACCINES (2020)

Article Allergy

Intradermal Phleum pratense allergoid immunotherapy. Double-blind, randomized, placebo-controlled trial

Francisco Javier Sola Martinez et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2020)

Review Immunology

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy

Max E. Kirtland et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Allergy

Intralymphatic Immunotherapy: Update and Unmet Needs

Gabriela Senti et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)

Article Allergy

A Fusion Protein of Derp2 Allergen and Flagellin Suppresses Experimental Allergic Asthma

Wenzhi Tan et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)

Article Allergy

Development and characterization of an allergoid of cat dander for immunotherapy

J. P. Sola et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2018)

Review Allergy

Modified Allergens for Immunotherapy

Pattraporn Satitsuksanoa et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2018)

Article Pharmacology & Pharmacy

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines

Jiemin Wang et al.

DRUG DELIVERY (2018)

Review Biotechnology & Applied Microbiology

Development of new hepatitis E vaccines

Yufeng Cao et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Review Allergy

DNA and mRNA vaccination against allergies

Sandra Scheiblhofer et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy

Pannathee Prangtaworn et al.

SCIENTIFIC REPORTS (2018)

Article Medicine, General & Internal

AR101 Oral Immunotherapy for Peanut Allergy

Brian P. Vickery et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Allergy

Skin as an immune organ and clinical applications of skin-based immunotherapy

J. Andrew Bird et al.

WORLD ALLERGY ORGANIZATION JOURNAL (2018)

Article Allergy

Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy

Angelika Tscheppe et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2017)

Article Allergy

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children

Felicia A. Rabito et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Review Biotechnology & Applied Microbiology

Immunotherapy of house dust mite allergy

Lin Yang et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)

Review Allergy

Quality requirements for allergen extracts and allergoids for allergen immunotherapy

J. Zimmer et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2017)

Article Otorhinolaryngology

New routes of allergen immunotherapy

Mitat Aricigil et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2016)

Review Immunology

Allergen immunotherapy for birch pollen-allergic patients: recent advances

Philippe Moingeon et al.

IMMUNOTHERAPY (2016)

Review Immunology

Grass pollen immunotherapy: where are we now

Peter A. Wurtzen et al.

IMMUNOTHERAPY (2016)

Article Allergy

Pathways through which asthma risk factors contribute to asthma severity in inner-city children

Andrew H. Liu et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Immunology

VTX-1463, a novel TLR-8 agonist, attenuates nasal congestion after ragweed challenge in sensitized beagle dogs

Christopher M. Royer et al.

IMMUNITY INFLAMMATION AND DISEASE (2016)

Article Allergy

Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy

Laurian Zuidmeer-Jongejan et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2015)

Article Allergy

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy

Margarete Focke-Tejkl et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Allergy

IgE-Binding Epitope Mapping and Tissue Localization of the Major American Cockroach Allergen Per a 2

Mey-Fann Lee et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2015)

Review Allergy

Aluminium in Allergies and Allergen immunotherapy

Erika Jensen-Jarolim

WORLD ALLERGY ORGANIZATION JOURNAL (2015)

Article Allergy

The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma

Kai-Michael Beeh et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Review Biochemistry & Molecular Biology

Key roles of adjuvants in modern vaccines

Steven G. Reed et al.

NATURE MEDICINE (2013)

Article Allergy

Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy

Matthias Volkmar Kopp et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)

Review Immunology

Regulatory T cell subsets in filarial infection and their function

Simon Metenou et al.

FRONTIERS IN IMMUNOLOGY (2013)

Review Allergy

Immunotherapy with peptides

D. Moldaver et al.

ALLERGY (2011)

Article Medicine, General & Internal

Clinico-immunological changes post-immunotherapy with Periplaneta americana

Deepsikha Srivastava et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Pharmacology & Pharmacy

Immunotherapy for allergies and asthma: present and future

Shyam S. Mohapatra et al.

CURRENT OPINION IN PHARMACOLOGY (2010)

Article Allergy

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

Marc Massanari et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Article Immunology

Towards an understanding of the adjuvant action of aluminium

Philippa Marrack et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Allergy

Lipopolysaccharides modulate allergen-specific immune regulation in a murine model of mucosal tolerance induction

Kerstin Gerhold et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)

Article Immunology

Immunoadjuvant effects of polyadenylic : polyuridylic acids through TLR3 and TLR7

Takahiro Sugiyama et al.

INTERNATIONAL IMMUNOLOGY (2008)

Article Allergy

Cockroach allergen reduction by cockroach control alone in low-income urban homes: A randomized control trial

Michelle L. Sever et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Review Allergy

Mechanisms of allergen-specific immunotherapy

Muebeccel Akdis et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Article Environmental Sciences

Integrated pest management in an urban community: A successful partnership for prevention

BL Brenner et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2003)

Article Public, Environmental & Occupational Health

On the front lines: An environmental asthma intervention in New York City

PL Kinney et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2002)